- Investing Ideas
- /
- Top Growth Stocks
Top Swedish (OMX) Growth Stocks
UPDATED Jun 29, 2022
What are the best Swedish (OMX) Growth Stocks?
According to our Simply Wall St analysis these are the best Swedish growth companies. We look for companies with high forecasted growth and healthy balance sheets that can deliver sustained growth over the long term.
Our criteria to find Top Growth Companies
Growth
- Companies with sustained revenue growth that outperforms the market are attractive to investors. These companies are most likely to appreciate in share price over time.
What do we look for?
- Is the company forecast to have high earnings growth.
Healthy Balance Sheet
- A healthy balance sheet is essential to drive growth opportunities and sustain the business.
- Repayments on debt take precedence over other initiatives to improve shareholder returns, so investors want to make sure the company is comfortably positioned to cover its debts.
What do we look for?
- Does the company have a manageable level of debt.
- Is the company able to cover its interest repayments.
40 companies meet this criteria in the Swedish market
Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: CALTX is expected to become profitable in the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 98.7% below our estimate of its fair value
Earnings are forecast to grow 60.26% per year
Risks
Shareholders have been diluted in the past year
Volatile share price over the past 3 months
Flexion Mobile Plc operates a distribution platform for third party free-to-play games on the Android market worldwide.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: FLEXM's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 43.1% below our estimate of its fair value
Earnings are forecast to grow 54.65% per year
Became profitable this year
Risks
Does not have a meaningful market cap (SEK788M)
Tempest Security AB (publ) provides security and protection solutions worldwide.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: TSEC is expected to become profitable in the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 90.6% below our estimate of its fair value
Earnings are forecast to grow 77.71% per year
Risks
Does not have a meaningful market cap (SEK223M)
Shareholders have been diluted in the past year
Mentice AB (publ) provides endovascular simulation solutions to teaching entities, healthcare systems, and medical device manufacturers.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: MNTC is expected to become profitable in the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 45.9% below our estimate of its fair value
Earnings are forecast to grow 96.96% per year
Risks
Shareholders have been diluted in the past year
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: RVRC's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 75% below our estimate of its fair value
Earnings are forecast to grow 20.06% per year
Earnings grew by 99% over the past year
Risks
High level of non-cash earnings
Camurus AB (publ), a pharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, Japan, and internationally.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: CAMX is expected to become profitable in the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 83.2% below our estimate of its fair value
Earnings are forecast to grow 49.97% per year
Earnings have grown 4.8% per year over the past 5 years
Risks
No risks detected for CAMX from our risks checks.
Genovis AB (publ.) designs, develops, and sells tools for development of drugs for customers in the pharmaceutical and medical device industries.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: GENO's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 56.6% below our estimate of its fair value
Earnings are forecast to grow 55.56% per year
Earnings grew by 299.3% over the past year
Risks
No risks detected for GENO from our risks checks.
MIPS AB (publ) manufactures and sells helmet-based safety systems in North America, Europe, Sweden, Asia, and Australia.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: MIPS's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 37.7% below our estimate of its fair value
Earnings are forecast to grow 26.95% per year
Earnings grew by 81.9% over the past year
Risks
High level of non-cash earnings